Oxis Turbohaler 12 (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxis Turbohaler 12, is a long‑acting bronchodilator presented as an inhalation device for inhalation use. It provides sustained relaxation of airway smooth muscle and is used in the management of chronic obstructive pulmonary disease and asthma in adults. GNH USA supplies Oxis Turbohaler 12 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oxis Turbohaler 12 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Formoterol fumarate dihydrate is a bronchodilator that acts on the airways to improve airflow in chronic respiratory diseases.

- Asthma: improves lung function and reduces symptoms such as wheezing and shortness of breath. - Chronic obstructive pulmonary disease (COPD): helps maintain open airways and reduces the frequency of exacerbations. - Exercise‑induced bronchoconstriction: provides pre‑exercise relief of airway narrowing. - Seasonal allergic rhinitis: alleviates nasal congestion associated with allergic inflammation. - Chronic bronchitis: supports better airway patency.

Formoterol fumarate dihydrate may elicit a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects: - Throat throat tough t ​        -              ewline Serious or Rare  ​     t   t  t  t t

t  t  ewline   ewline -   t. -  . -  t. -  t. -  t. -  t. -  ewline  t. -  ewline. -  t. -  -  t. -  - ",